Stephanie A. Halasohoris

发表

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis

S. Tanaka, J. Steenbergen, Judith Steenbergen, 2017, Antimicrobial Agents and Chemotherapy.

Efficacy of Delafloxacin against the Biothreat Pathogen Burkholderia pseudomallei

M. Hickman, Stephanie A. Halasohoris, S. McCurdy, 2021, Antimicrobial agents and chemotherapy.

In Vitro and In Vivo Characterization of Tebipenem, an Orally Active Carbapenem, against Biothreat Pathogens

M. Pucci, Akash Jain, Nicholas P Clayton, 2021, Antimicrobial Agents and Chemotherapy.

In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods

B. Purcell, Stephanie A. Halasohoris, H. Heine, 2017, Antimicrobial Agents and Chemotherapy.

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

D. Szabo, L. Otvos Jr, E. Ostorházi, 2018, Front. Chem..

A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia

N. Vietri, G. Palacios, J. Ladner, 2017, PloS one.

Demonstration of the Broad-Spectrum In Vitro Activity of Finafloxacin against Pathogens of Biodefense Interest

M. Richards, S. Harding, P. Russell, 2019, Antimicrobial Agents and Chemotherapy.

Origins of Yersinia pestis Sensitivity to the Arylomycin Antibiotics and the Inhibition of Type I Signal Peptidase

F. Romesberg, Jian Liu, Jeremy C. Miller, 2015, Antimicrobial Agents and Chemotherapy.

Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice.

D. DeShazer, D. Waag, W. Ribot, 2007, Diagnostic microbiology and infectious disease.

Binding Sites of Anti-Lcr V Monoclonal Antibodies Are More Critical than the Avidities and Affinities for Passive Protection against Yersinia pestis Infection in a Bubonic Plague Model

Sarah L. Keasey, Jennifer L. Dankmeyer, P. Worsham, 2020, Antibodies.

In Vitro Antibiotic Susceptibilities of Yersinia pestis Determined by Broth Microdilution following CLSI Methods

P. Worsham, B. Purcell, Stephanie A. Halasohoris, 2015, Antimicrobial Agents and Chemotherapy.

Efficacy of delafloxacin against the biothreat pathogen Bacillus anthracis.

C. Klimko, C. Cote, M. Hickman, 2023, The Journal of antimicrobial chemotherapy.

In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens

R. Panchal, D. Biek, Stephanie A. Halasohoris, 2021, The Journal of Antibiotics.

Origins of Yersinia pestis Sensitivity to the Arylomycin Antibiotics and the Inhibition of Type I Signal Peptidase

F. Romesberg, Jian Liu, Jeremy C. Miller, 2015, Antimicrobial Agents and Chemotherapy.